Carmel Shalev

Dr Carmel Shalev is a human rights lawyer and ethicist, who earned her doctoral degree from Yale Law School and pursued a public interest and academic career in health, human rights and bioethics. She now teaches at academic institutions in Israel and abroad, including Haifa University Faculty of Law, and works as a consultant on health and research ethics for local and international public interest organizations such as WHO and UNAIDS.

Between 1998 and 2004 Dr. Shalev established and directed the Unit for Health Rights and Ethics at the Gertner Institute for Health Policy Research, Israel. Previously she served as chief legal advisor to the Israel Ministry of Health. Between 1994 and 2000 Dr. Shalev served as an independent expert member on the United Nations Committee on the Elimination of All Forms of Discrimination Against Women (CEDAW), and between 1999 and 2005 she served on the Israel National Committee for Genetic Experiments in Human Beings. She has been a member of the Scientific and Ethical Review Group (SERG), of the WHO Special Programme of Research, Development and Research Training in Human Reproduction since 1997.

Dr. Shalev has published extensively in her areas of expertise, including Birth Power: The Case for Surrogacy (Yale University Press, New Haven, 1989); and Health and Human Rights in Israeli Law (Ramot, Tel Aviv University Press, 2003) [Hebrew]. Her major current interest is in the ethics of repro-genetics. In 2009 she founded the Department for Reproduction and Society at the International Center for Health, Law and Ethics at Haifa University, Israel, which she continues to head.



Carmel Shalev | 20 Sep 2014 |
tags: commercialization, interviews, surrogacy
An Israeli bioethicist is organising a conference on the rapidly growing market in surrogate mothers and babies.
 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Recent Posts
Australia launches inquiry into safety and ethics of transgender medicine
18 Aug 2019
Fertility becomes a global money-spinner 
18 Aug 2019
‘Sperm sharing’ schemes in UK make IVF cheaper
18 Aug 2019
Push in Germany for legalisation of surrogacy
18 Aug 2019
Should countries compete to have the most permissive stem cell regulations?
18 Aug 2019

 Archive
Aug 2019 | Jul 2019 | Jun 2019 | more >>

Home | About Us | Contact Us | rss RSS | Archive | Bookmark and Share | michael@bioedge.org

BioEdge - New Media Foundation Ltd © 2004 - 2019